Tag Archives: science
We extend our congratulations to the honorees: Reps. Frank Wolf (R-VA) and Chaka Fattah (D-PA); actress Glenn Close and her family for their work to end the stigmas and misunderstandings surrounding mental illness; Leroy Hood, MD, PhD, president of the Institute for Systems Biology; Kathy Giusti, founder and CEO of the Multiple Myeloma Research Foundation (MMRF); Reed Tuckson, MD, managing director of Tuckson Health Connections; and The Progeria Research Foundation (PRF).
While much has been done to advance research, we have a long way to go.
“Few out there seem to connect the dots to understand that federal funding is essential to develop the foundation of knowledge which is essential for American enterprise in developing the products and therapies that make our lives longer, healthier, and happier,” said Research!America Chair and former Member of Congress The Hon. John E. Porter in remarks at the Dinner. “There’s nothing more important to our future than investments in science, research, innovation and technology.”
And we agree! Contact your representatives and tell them to make research funding a higher priority.
Distinguished guests included current and former members of Congress and administration officials. Sen. Angus King (I-ME), Rep. David Price (D-NC), Rep. Nita Lowey (D-NY) and Rep. Scott Peters (D-CA), joined the celebration. Research!America board members, The Hon. Mike Castle, The Hon. Kweisi Mfume and The Hon. Patrick Kennedy also attended the event along with former Congresswoman Mary Bono , former HHS Secretary The Hon. Dr. Louis Sullivan, NIH Director Dr. Francis Collins, NSF Acting Director Dr. Cora Marrett, and PCORI Executive Director Dr. Joe Selby.
Click here to see photos.
Dear Research Advocate:
People everywhere are captivated by the world-class athletes competing at the Winter Olympics. The personal commitment, dedication and motivation on display is certainly an essential ingredient for medalling, but it is not sufficient: Each nation fielding a team must commit to supporting sustained excellence. And both the public and private sectors play a role. There are some interesting parallels to science and innovation — we don’t see it in the public eye every day but when it comes to the fore, it’s the kind of success that affirms the human spirit in a compelling way. When lives are saved with a new therapy or new vaccine, we all take heart and we celebrate, perhaps not realizing that it took years of training, teamwork and ‘practice’ to arrive first at the finish line. What it takes to remain internationally competitive in any global arena — very much including science and innovation — is the combination of well-trained and dedicated people at the top of their form, plus a firm national commitment over a many-year period.
In journalistic coverage that we don’t see often enough, a special report in Monday’s Washington Post describes how government-funded basic research has led to new cancer therapies and a potential “cancer vaccine” currently undergoing testing in the private sector. This is a perfect example of the well-honed teamwork that is our public-private sector research enterprise. But without public sector financing, private sector capital and a commitment to STEM education, the pipeline will not only dry up, its infrastructure will crumble. As Congress readies itself to receive and respond to the president’s budget in early March, email your representatives in Washington to let them know that when it comes to medical research and innovation, the U.S. must continue to go for the gold. That means recommitting to global leadership.
With long-standing champions of science retiring, spurring that commitment will undoubtedly be a steeper climb. Congressman Rush Holt, a physicist whose legacy in Congress as a champion for science, research and STEM education is truly superlative, announced his retirement on Tuesday. His is the latest retirement in a string that reminds us how pivotally important one Member of Congress can be in advancing the best interests of our nation, and it underscores the importance of cultivation of new champions.
Tomorrow morning several NIH directors (NINDS, NICHD, NHLBI and NIAMS) will appear on C-SPAN’s Washington Journal. The call-in program airs from 7:30 – 9:30 a.m. Eastern. I hope you take advantage of participating in this nationally broadcast program. Ask the directors what they think it will take to assure gold-medal winning research now and in the years ahead! Here are the Washington Journal’s phone numbers for calling in tomorrow:
- Democrats: 202-585-3880
- Republicans: 202-585-3881
- Independents: 202-585-3882
- Outside U.S.: 202-585-3883
I hope to hear your voice on the air!
Dear Research Advocate,
Ironically, the government is closed down today. But that’s due to a major snowstorm, not because of failure to agree on increasing the debt limit! Agreeing to increase the debt limit is an encouraging sign that this Congress, weighed down as it is by ideological and political differences, and with record- low approval rankings from the public, can get its job done! Our job is to be sure research is a top priority in this election year — spoken of with conviction by all candidates and by the media and others who influence them.
Standing tall among Members of Congress who champion science are the Chair and Ranking Member of the House Appropriations’ Commerce, Justice, Science and Related Agencies subcommittee, Rep. Frank R. Wolf (R-VA-10) and Rep. Chaka Fattah (D-PA-02). At our upcoming March 12 Advocacy Awards dinner, Research!America will honor Reps. Wolf and Fattah with the Edwin C. Whitehead Award for Medical Research Advocacy, saluting their tireless efforts to champion policies that promote federal and private sector medical research and innovation. Be sure to join us!
Robert Samuelson observes in The Washington Post that Congress, whether by action or inaction, is making too many decisions “on the sly,” without real public awareness or comprehension. Samuelson says that in so doing Congress is compromising priorities like defense and medical research while simultaneously failing to address tax and entitlement reform. I think it is telling that he chose to identify the loss of purchasing power by the NIH as one of three critical problems created as our elected representatives fail to find a clear path through the ideological storm. One of these days they will make those major decisions, and that’s when it will pay off that research has been well-positioned as a top national priority. We must continue to make the case and make it forcefully.
Even as we work to keep our issue in the forefront of big-picture policy change, we must at the same time make our case via the appropriations process, which is proceeding, for the first time in years, according to ‘regular order.’ Right now, in FY14, funding for NIH is lower than in FY12 (and in constant dollars is lower than FY03!) — a shortfall that makes absolutely no sense if the goal is to serve the best interests of America and Americans. Other science agencies are underfunded as well, and the policy environment for private sector research and innovation is not compatible with our nation’s goals of global leadership. As you prepare to pound the pavement and take to social media to make the case to appropriators for research, take inspiration and new data from the following:
- Strong arguments for changing course by Dr. Claire Pomeroy, president of the Albert and Mary Lasker Foundation in The Huffington Post.
- Updated facts on science and research in the U.S.: National Science Board Science and Engineering Indicators 2014.
- Creative, unique short videos demonstrating the importance of federal investments in biomedical and biological science from the winners of FASEB’s second Stand Up for Science Video Competition.
And this: According to the National Retail Federation, Americans are expected to spend $17.3 billion in celebration of Valentine’s Day. That amount would fund the National Heart, Lung and Blood Institute for more than five years! We are a wealthy nation; we can well afford to spend more on the future of health than we currently are.
Guest blog post by the American Chemical Society.
Can a value be placed on innovation? What is the economic impact of science and technology research? What is the return on investment of research and development?
These questions were addressed at the January 30, 2014, American Chemical Society Science & the Congress briefing, Measuring Economic Growth: R&D Investments, held on Capitol Hill. Moderated by the National Academies’ Stephen Merrill, PhD, panelist Steve Landefeld, PhD, of the Bureau of Economic Analysis spoke on how R&D numbers are now included in gross domestic product reports. Carol Corrado, PhD, of The Conference Board and Georgetown University explained how this captures “intangible” portions of the economy.
Researchers and scientists discover knowledge. Inventors and engineers apply understanding into tangible products like medicines, cars and computer software. Artists use technology from pens and paints to instruments and computers to produce works of entertainment. R&D thus seeds economic impact.
To illustrate R&D’s economic impact, IBM Chief Economist Martin Fleming, PhD, remarked that the Super Bowl attracts more viewers thanks to computer science: The 1st down line appears as “paint” on the field and not moving players. This TV “magic” results from scientific research of light and information. Camera sensors turn images into data, the Internet exchanges big data packages, then computer graphics paint on the TV screen in real time [with credit to Hollywood for development]. That the Super Bowl’s marketing power translates into significant consumer spending is hard to deny.
Andrew Lo, PhD, of MIT’s Sloan School of Management shows how R&D numbers are candy to financial markets to drive investment decisions that provide for economy-growing business. He showed that billions of dollars put into scientific and medical research in the War on Cancer has led to lifesaving drugs. The lives saved by these drugs contribute trillions of dollars to the economy. When considering multi-billion dollar federal spending, Lo states, “You can’t manage what you can’t measure.”
ACS Science & the Congress Project holds briefings in Washington, DC, to educate and inform Members of Congress, their staffs and policy professionals on issues of science and technology. Previous installments are available at https://vimeo.com/channels/acssciconhill and https://vimeo.com/channels/sciencesocietychallenges. For more information on these events open to the public, contact firstname.lastname@example.org.
A Weekly Advocacy Message from Mary Woolley: Americans say scientists aren’t communicating the impact of science
Dear Research Advocate:
Since President Obama declared 2014 as a “year of action” in his State of the Union address, several people have asked my view on how the president might advance science by executive order. Some options that come to mind: the president can (1) pump up the budget for NIH and other science agencies in his FY15 budget blueprint, scheduled for release in early March; (2) require an assessment of the impact on innovation, access and economic growth before making any administration-initiated cuts to drug, biologic or device reimbursement; and (3) designate a task force to formulate a national science strategy.
As several Members of Congress noted after the president’s address, American progress can’t be achieved solely by executive order. But rather than debating constitutional authority, it’s past time for the administration and Congress to work together to advance the priorities of the Americans who hired them. Congress is reportedly getting a jump-start on the FY15 appropriations process, so this is perfect timing for advocates to make the case for science funding levels that capitalize on the multi-faceted return on that investment. Continue reading →
Dear Research Advocate:
During his State of the Union address Tuesday, President Obama acknowledged the important role federally funded research plays in maintaining our global competitive edge and referenced the harm done to basic science by sequestration. Using the example of vaccines, he highlighted the importance of applied research, not only for our health but for the strength of our economy. See my statement about the address here. For the president to succeed in achieving a “breakthrough year for America” — a theme in his address that he is repeating in appearances across the nation — we urge him to put science and innovation at the forefront. I emphasized this in a letter we sent to him today.
During the State of the Union Congressional Debrief sponsored by The Atlantic and National Journal, I asked Rep. Diana DeGette (D-CO-01) whether Congress would work with the president to undo the damage done to basic research. She said that she and others are working in a bipartisan way to assure that “America is the top nation for research in the world.” In an effort to combat the underfunding and underappreciation for federally funded science, our award-winning voter education initiative is launching shortly — “Ask Your Candidates! Is Medical Progress a Priority?” It is critical that we all ask congressional candidates their views about assuring medical progress. I encourage you to participate in this important campaign as we enter the primary and then general election season.
Last week, the attention of the business community and other leaders was trained on Davos, Switzerland. Comments by Harvard economist Larry Summers at the World Economic Forum put U.S. underinvestment in medical progress into context. It’s a message worth repeating. “We are spending 25 [percent] less on research in the life sciences than we were five years ago. That is a deficit with huge human consequences. We have to move on from viewing deficits in terms of financial debt and focus on the deficits we are bequeathing to our children.”
Please join me in extending hearty congratulations to Research!America Chair and former Congressman John Edward Porter, who will receive the National Academy of Sciences’ most prestigious award, the Public Welfare Medal, at a ceremony this spring. This award, rarely given to a non-scientist, recognizes John for decades of advocacy on behalf of medical research and salutes his many accomplishments, including leadership in the Congress for medical and all scientific research, resulting in increased federal support of our nation’s science agencies. He continues his leadership for science today!
Statement by Research!America president and CEO Mary Woolley on President Obama’s State of the Union Speech
January 29, 2014
It’s heartening President Obama chose to emphasize in his speech the significance of federally funded basic research and the need to undo the damage that has been done to it in recent years with deep spending cuts. The president used language the science community epitomizes – he spoke of working for “breakthroughs” and a nation motivated by opportunity. But actions speak louder than words. Congress and the White House must treat research and innovation as the health and economic imperative it has always been and invest in expanding our nation’s research capacity. It bears on business and job creation in both the research and manufacturing sectors; it bears on our nation’s ability to slow or stop the progression of disabling, deadly and federal deficit-perpetuating diseases like Alzheimer’s, cancer and heart disease; and most importantly, it bears on the quality of life for Americans now and in the future. Our elected officials must eliminate sequestration for good and support medical innovation at the level of scientific opportunity to ensure more breakthroughs in coming years.
Dear Research Advocate:
The omnibus appropriations bill about to become law demonstrates that bipartisanship and pseudo-regular order is achievable. We won’t know for sure if we have true “regular order” until Congress proceeds through the FY15 appropriations process in a timely manner — something that hasn’t happened for many years. The importance of regular order is that the public’s interests are heard from in hearings, and every Member of Congress participates in priority-setting instead of only having the opportunity to cast a single up-or-down vote. Regular order is worth working toward, since at least one priority we all care about did not fare well in the omnibus.
The omnibus has failed to fund NIH at a level that fully reverses the impact of sequestration on the agency’s baseline funding level, much less establishes a growth trend that can fully unleash the potential inherent in the sequencing of the human genome and other research breakthroughs. As Drs. Paul Stoffels and Alan Leshner make crystal clear in an op-ed in Politico Magazine, we can’t settle for “better than sequestration.” If our nation wants to thrive, we need to grow our investment in science. Between 2010 and 2013, U.S. federal investments in science fell to less than 1% (.82%) of the economy. That’s the lowest it’s been in 50 years! As you know, this comes at a time when foreign nations are rapidly ramping up their R&D programs and taking a page from our playbook. Remember that global competitiveness in medical research is a pivotal determinant of our global economic competitiveness overall. We aren’t just talking about the future of our scientific enterprise, we are talking about the future of our economy. Are we truly willing to cede leadership in global R&D? (See also our statement cited in The Hill and other media outlets, as well as my interview today with UDC.) Continue reading →
Dear Research Advocate:
Following the lead of Budget Chairs Murray (D-WA) and Ryan (R-WI-01), Appropriations Chairs Mikulski (D-MD) and Rogers (R-KY-05) are trying to end the recent string of continuing resolutions and craft a funding compromise that advances the nation’s best interests. Congress may miss its January 15 deadline for appropriations, but it won’t likely shut down the government. We anticipate a short-term extension of the deadline while appropriators in both chambers work to craft an omnibus bill that reflects today’s priorities instead of blind, across-the-board cuts. It’s about time, you’re thinking (and I agree!) that Congress gets back to “regular order.” Regular order includes listening to constituents, content experts and advocates. That’s where you come in. Here is a link to the appropriators and the contact information for their legislative directors (LDs). Emailing their LDs may be the fastest route to reaching the members themselves. Tell them that you endorse their determination to appropriate in keeping with national priorities — and tell them what your priorities are. Continue reading →
Dear Research Advocate:
The end of the year is a good time to think ahead and consider our nation at the end of the decade; how will we fare in the world order? My letter this week to the editor of the New York Times highlights poll data indicating that Americans don’t believe the U.S. will be the world leader in science and technology by 2020. This data reflects opinions grounded in numerous media reports on China’s accomplishments and determination to lead the world in science. Chinese accomplishments in space of late and their plans for a space station in 2020 ought to be a 21st century “Sputnik moment” for the U.S. It should be a wake-up call to policy makers: get serious about fueling our nation’s underpowered research and education infrastructure if we expect to compete globally in the years ahead. As NIH Director Dr. Francis Collins noted in his Washington Post op-ed this week, we’re at a “critical juncture” in biomedical research. Do we pursue opportunities derived from recent medical breakthroughs or squander them with insufficient funding for research? Continue reading →
A Weekly Advocacy Message from Mary Woolley: Pope Francis is the Man of the Year; do you know what the Word of the Year is?
Dear Research Advocate:
Here’s a holiday surprise! I am not referring to the budget deal, but to the fact that Merriam-Webster’s 2013 word of the year — determined via the greatest increase in online searches — is “science.” I find this to be refreshing news, providing evidence that interest in science is growing, which in turn is an indication of substantial room for researchers and research advocates to contribute to public understanding and support of science. We appear to have an opportunity ready for the taking to overcome the “invisibility” problem that contributes to holding decision makers back from assigning a higher priority to science.
And speaking of those decision makers, we have a budget deal! While modest at best, it is a starting point for bipartisanship in serving the public’s interest. We can build on this foundation. Please add your voice, as funding is being determined by appropriators. Click here to urge your Members of Congress to support robust funding for NIH, NSF, FDA, CDC and AHRQ. This week, we’ve released our annual Health R&D Investment report, which could provide new context for your messages. The report shows some gains in philanthropy, industry, and voluntary health association support for research but notes woefully inadequate federal funding, especially given what’s at stake for our health and our economy. Continue reading →
By Alan G. Kraut, Executive Director of the Association for Psychological Science
In the minds of many people, there is a separation between biomedical research and behavioral research. But that separation is artificial. Behavior is at the core of many health problems. Six out of 10 of the leading causes of premature death, including heart disease, diabetes, and stroke, are linked in part to genetic influences but also to controllable behaviors like physical inactivity, poor diet and smoking.
Our 25,000 members are scientists and educators at the nation’s universities and colleges, conducting federally funded basic and applied, theoretical, and clinical research. They look at such things as the connections between emotion, stress, and biology and the impact of stress on health; they look at ways to manage debilitating chronic conditions such as diabetes and arthritis as well as depression and other mental disorders; they look at how genes and the environment influence behavioral traits such as aggression and anxiety; and they address the behavioral aspects of smoking and drug and alcohol abuse.
Just as there exists a layered understanding, from basic to applied, of how molecules affect brain cancer, there is a similar spectrum for behavioral research. Continue reading →
A Weekly Advocacy Message from Mary Woolley: Call in Friday morning to help change the national conversation
Dear Research Advocate:
Research!America, in partnership with the American Society of Hematology, released a new poll on Tuesday, revealing strong feelings about the consequences of recent fiscal debacles. A majority (57%) of Americans, across party lines, believe that the government shutdown in October caused significant harm to programs like medical research, defense and education, programs that Americans value. It is not difficult to connect the dots between fiscal dysfunction and the future of our nation: More Americans than ever believe that our nation’s global leadership in science, technology and research will soon be a thing of the past,with 73% saying we will lose global leadership by 2020 — just six years from now. A plurality says China will surpass us by then. This perception is not far off base. China and other countries, including most recently Mexico, are making major commitments to their research and innovation infrastructure. They are determined to drive their economy and contribute to health and prosperity by following what was for years the leadership example set by the U.S.
Last month, following President Enrique Peña Nieto’s leadership, the Mexican Congress increased the budget for the primary national science and technology agency by 20% for 2014 and increased the nation’s overall science budget by 12%. Battelle predicts that China’s dramatic increases in federal research spending have positioned the nation to overtake the U.S. in total R&D investment within a few short years. It’s high time we match the bold visions of Mexico, China and many other nations. Continue reading →
Majority of Americans Believe Another Government Shutdown Likely in Coming Months; Last One Harmful to Medical Research
New National Poll Reveals Many Respondents Predict China will Surpass U.S.
in Science and Innovation by 2020
ALEXANDRIA, Va.—December 3, 2013—Nearly two-thirds (65%) of Americans say it’s likely there will be another government shutdown in the months ahead as Congress continues to debate deficit and budget issues, according to a new national public opinion poll commissioned by Research!America and the American Society of Hematology. This sentiment is shared across party affiliations: Democrats (66%), Republicans (65%) and Independents (65%). There is also consensus across party lines that government dysfunction has consequences. A majority of Americans (57%) say the shutdown in October caused significant harm to many government-funded programs including medical research, defense and education. Democrats (68%) and about half of Republicans (49%) and Independents (51%) agree.
On the topic of sequestration, a plurality (44%) says Congress must tackle tax and entitlement reform to reduce the deficit instead of continuing the 10 years of across-the-board cuts; another 16% say sequestration is not the right way to reduce the deficit. Less than a quarter (23%) believe the across-the-board cuts are a way of ensuring that many government programs share the pain, and 17% say they’re not sure. In general, 62% of Americans say they’re concerned about the long-term effects of sequestration on advances in health care such as the development of new drugs and other treatments.
“Our poll demonstrates uneasiness among many Americans about the ramifications of deep spending cuts to programs that are critical to our health and well-being,” said Mary Woolley, president and CEO of Research!America. “Americans want Congress to reach a budget deal that protects medical and health research, at least in part because of concern that our nation is at risk of losing our global leadership position in science and innovation.” Continue reading →
Dear Research Advocate:
It has been a week since the Budget Conference Committee’s first meeting. The next public meeting is scheduled for November 13. Staffs are at work, and various Members are talking. There are no concrete signs of progress. What I keep coming back to is the failure of our nation’s decision makers to recognize and act on the reality that the priorities of Americans are reflected in both discretionary and entitlement programs. The persistence of sequestration underscores Congress’ inability to make decisions and choose priorities. The sequestration era has run its course, dealing Congress record lows in terms of public support; it’s past time to end the era and move on.
Recently I shared my letter to the Budget Conference Committee; it argued for an end to sequestration, pointing out the importance of investing in medical research as a pragmatic strategy for decreasing the national debt and deficit. This week I followed up with a letter on the importance of health research, pointing out how it helps identify smart medical innovation and optimal health care financing and delivery. The letter showcases the essential role of health economics, health services, public health, behavioral and social science research in assuring quality medical innovation and smart health care delivery. We are concerned that if the research stakeholder community at large does not speak out for this critical research, it will be compromised or even defunded altogether. Please join us in raising your voice. Continue reading →